RxDoctor Payments Data

Brian Bizik

Physician Assistant · Twin Falls, IDNPI 1932166956

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (42.3%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 20.1%. 2025 is the largest year on record at $29,527, 2.5 times the $11,675 reported in 2021. Among physician assistant clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$80,943in general payments, 2019–2025

Across 219 payments — averaging $369.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organon$16K
  • Dermavant Sciences, Inc.$14K
  • Grifols USA, LLC$13K
  • Regeneron Healthcare Solutions, Inc.$10K
  • Genentech USA, Inc.$9K
  • AstraZeneca$5K
  • plus $14K from 13 others

What the payments were for

  • Consulting fees$26,15632%
  • Speaking & faculty fees$34,26142%
  • Travel & lodging$12,36315%
  • Food & beverage$8,16310%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$80,943 in reported general payments places this provider in the 95th percentile of 1,027 physician assistant providers in Idaho.

See all physician assistant providers in Idaho

Most prescribed under Part D

DrugClaimsCost to plans & patients
Stiolto RespimatTiotropium Br/Olodaterol Hcl29$17,803
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$14,715
Albuterol Sulfate HfaAlbuterol Sulfate72$1,842
Azithromycin33$230
Montelukast Sodium11$65
Triamcinolone Acetonide11$65
Prednisone37$61

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimStiolto Respimat$2,377$17,80329 claims
GSKTrelegy Ellipta$44$14,71519 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,027 physician assistant providers in Idaho.

Other physician assistant in Twin Falls

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →